🔗 Share this article

Treasury head Rachel Reeves has announced she is preparing "focused measures to deal with household expense challenges" in the forthcoming Budget.

In comments to media outlets, she emphasized that curbing price rises is a shared task of both the government and the Bank of England.

The United Kingdom's price growth is projected to be the highest among the Group of Seven advanced economies this calendar year and the following year.

Potential Energy Cost Measures

Reports indicate the government could take action to reduce energy bills, such as by slashing the current 5% level of value-added tax applied on energy.

A further possibility is to reduce some of the regulatory levies presently included in bills.

Budgetary Limitations and Expert Predictions

The government will receive the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much room there is for such measures.

The consensus from the majority of experts is that the Chancellor will have to introduce higher taxes or budget cuts in order to meet her voluntary debt limits.

Previously on the same day, analysis showed there was a £22bn shortfall for the Treasury chief to fill, which is at the lower end of expectations.

"It is a shared job between the central bank and the government to further reduce some of the causes of inflation," Reeves told reporters in Washington, at the conferences of the IMF and global financial institution.

Revenue Commitments and International Concerns

While a great deal of the focus has been on expected tax increases, the chancellor said the most recent data from the fiscal watchdog had not altered her vow to manifesto promises not to raise rates on earnings tax, VAT or National Insurance.

She attributed an "uncertain global environment" with rising international and trade concerns for the Budget revenue measures, likely to be focused on those "most able to pay."

Global Trade Disputes

Commenting on concerns about the United Kingdom's trade ties with the Asian nation she said: "The UK's national security invariably take priority."

Last week's announcement by China to strengthen trade restrictions on rare earths and other materials that are essential for high-technology manufacturing led US President the US President to suggest an additional 100% import tax on goods from China, raising the risk of an all-out commercial conflict between the two largest economies.

The American finance chief labeled the Chinese decision "economic coercion" and "a international production control attempt."

Inquired about considering the American proposal to join its battle with the Asian nation, the Chancellor said she was "extremely troubled" by Chinese measures and called on the Beijing authorities "not to put up barriers and limit trade."

She said the move was "harmful for the international commerce and creates additional challenges."

"It is my opinion there are fields where we must confront Chinese policies, but there are also valuable prospects to trade with Chinese markets, including banking sector and other areas of the economy. We've got to achieve that equilibrium right."

The chancellor also confirmed she was cooperating with international partners "on our own essential resources strategy, so that we are less reliant."

NHS Medicine Pricing and Investment

Reeves also recognized that the price the National Health Service pays for pharmaceuticals could go up as a consequence of current negotiations with the Trump administration and its drugs companies, in return for reduced taxes and capital.

Some of the world's largest drug companies have said in recent statements that they are either pausing or scrapping investments in the UK, with some blaming the low prices they are obtaining.

Recently, the Science Minister said the cost the health service pays for medicines would need to increase to prevent firms and drug research funding leaving the UK.

The Chancellor told media: "We have seen due to the pricing regime, that clinical trials, innovative medicines have not been available in the UK in the manner that they are in other European countries."

"We want to ensure that patients receiving treatment from the NHS are able to access the top critical drugs in the world. And so we are looking at this situation, and... looking to attract more investment into Britain."